Article
Improving toxicity screening and drug development by using genetically defined strains.
Methods in molecular biology (Clifton, N.J.) - 1 Jan 2010
Festing Michael F W
Abstract excerpt
According to the US Food and Drugs Administration (Food and Drug Administration (2004) Challenge and opportunity on the critical path to new medical products.) "The inability to better assess and predict product safety leads to failures during clinical development and, occasionally, after marketing". This increases the cost of new drugs as clinical trials are even more expensive than pre-clinical testing.One...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.